Assetmark, Inc Innoviva, Inc. Transaction History

Assetmark, Inc

$34.9 Billion
Q3 2024

A detailed history of Assetmark, Inc transactions in Innoviva, Inc. stock. As of the latest transaction made, Assetmark, Inc holds 154,890 shares of INVA stock, worth $2.76 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

154,890

Previous 147,722 4.85%

Holding current value

$2.76 Million

Previous $2.42 Million 23.41%

% of portfolio

0.01%

Previous 0.01%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 01, 2024	BUY	$16.33 - $20.04 $117,053 - $143,646	7,168 Added 4.85%	154,890 $2.99 Million
Q2 2024 Aug 13, 2024	BUY	$14.4 - $16.4 $97,272 - $110,781	6,755 Added 4.79%	147,722 $2.42 Million
Q1 2024 May 06, 2024	BUY	$14.56 - $16.78 $1.22 Million - $1.41 Million	84,028 Added 147.58%	140,967 $2.15 Million
Q4 2023 Feb 09, 2024	BUY	$12.32 - $16.27 $26,906 - $35,533	2,184 Added 3.99%	56,939 $913,000
Q3 2023 Oct 27, 2023	BUY	$12.37 - $13.89 $24,851 - $27,905	2,009 Added 3.81%	54,755 $711,000
Q2 2023 Aug 11, 2023	SELL	$11.39 - $13.72 $6,241 - $7,518	-548 Reduced 1.03%	52,746 $671,000
Q1 2023 May 05, 2023	BUY	$10.73 - $13.6 $140,992 - $178,704	13,140 Added 32.72%	53,294 $599,000
Q4 2022 Feb 10, 2023	SELL	$11.8 - $13.78 $51,577 - $60,232	-4,371 Reduced 9.82%	40,154 $532,000
Q3 2022 Nov 01, 2022	SELL	$11.61 - $15.22 $621,715 - $815,031	-53,550 Reduced 54.6%	44,525 $517,000
Q2 2022 Aug 03, 2022	BUY	$14.32 - $19.88 $140,450 - $194,983	9,808 Added 11.11%	98,075 $1.45 Million
Q1 2022 May 13, 2022	SELL	$15.39 - $20.25 $615 - $810	-40 Reduced 0.05%	88,267 $1.71 Million
Q4 2021 Feb 14, 2022	BUY	$15.91 - $18.72 $182,424 - $214,643	11,466 Added 14.92%	88,307 $1.52 Million
Q3 2021 Nov 12, 2021	BUY	$13.06 - $17.24 $91,171 - $120,352	6,981 Added 9.99%	76,841 $1.28 Million
Q2 2021 Aug 16, 2021	BUY	$11.45 - $13.96 $91,725 - $111,833	8,011 Added 12.95%	69,860 $937,000
Q1 2021 May 14, 2021	BUY	$11.06 - $12.87 $179,570 - $208,957	16,236 Added 35.6%	61,849 $739,000
Q4 2020 Feb 10, 2021	BUY	$9.33 - $12.48 $69,014 - $92,314	7,397 Added 19.36%	45,613 $565,000
Q3 2020 Nov 13, 2020	BUY	$10.33 - $14.49 $273,507 - $383,651	26,477 Added 225.55%	38,216 $399,000
Q2 2020 Aug 11, 2020	BUY	$11.49 - $15.26 $134,881 - $179,137	11,739 New	11,739 $164,000
Q1 2020 May 12, 2020	SELL	$8.11 - $15.23 $1,540 - $2,893	-190 Closed	0 $0
Q4 2019 Feb 11, 2020	BUY	$10.28 - $14.38 $51 - $71	5 Added 2.7%	190 $3,000
Q3 2019 Nov 13, 2019	SELL	$10.05 - $14.55 $261 - $378	-26 Reduced 12.32%	185 $2,000
Q2 2019 Aug 14, 2019	BUY	$13.1 - $14.95 $982 - $1,121	75 Added 55.15%	211 $3,000
Q1 2019 May 14, 2019	BUY	$13.69 - $20.06 $752 - $1,103	55 Added 67.9%	136 $2,000
Q3 2018 Nov 13, 2018	SELL	$13.63 - $15.7 $286 - $329	-21 Reduced 20.59%	81 $1,000
Q1 2018 May 16, 2018	SELL	$13.8 - $16.99 $27 - $33	-2 Reduced 1.92%	102 $2,000
Q4 2017 Feb 13, 2018	BUY	$11.73 - $14.75 $1,219 - $1,534	104	104 $1,000

Others Institutions Holding INVA

# of Institutions

227

Shares Held

78.9M

Call Options Held

37.6K

Put Options Held

300

View Full List

About Innoviva, Inc.

Ticker INVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 69,706,000
Market Cap $1.24B
Description
Innoviva, Inc. engages in the development and commercialization of pharmaceuticals in the United States and internationally. Its products include RELVAR/BREO ELLIPTA, a once-daily combination medicine consisting of a LABA, vilanterol (VI), an inhaled corticosteroid (ICS), and fluticasone furoate; ANORO ELLIPTA, a once-daily medicine combining a ...

More about INVA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Assetmark, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Assetmark, Inc with notifications on news.

Account